The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput genetic, epigenetic, and gene expression studies
View ORCID ProfileJoão Malato, View ORCID ProfileFranziska Sotzny, Sandra Bauer, View ORCID ProfileHelma Freitag, View ORCID ProfileAndré Fonseca, View ORCID ProfileAnna D Grabowska, View ORCID ProfileLuís Graça, View ORCID ProfileClara Cordeiro, View ORCID ProfileLuís Nacul, View ORCID ProfileEliana M Lacerda, View ORCID ProfileJesus Castro-Marrero, View ORCID ProfileCarmen Scheibenbogen, View ORCID ProfileFrancisco Westermeier, View ORCID ProfileNuno Sepúlveda
doi: https://doi.org/10.1101/2021.03.23.21254175
João Malato
1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
2CEAUL – Centro de Estatística e Aplicações, Faculdade de Ciências, Universidade de Lisboa, Lisbon, Portugal
Franziska Sotzny
3Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin and Berlin Institute of Health, Institute of Medical Immunology, Berlin, Germany
Sandra Bauer
3Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin and Berlin Institute of Health, Institute of Medical Immunology, Berlin, Germany
Helma Freitag
3Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin and Berlin Institute of Health, Institute of Medical Immunology, Berlin, Germany
André Fonseca
4Faculdade de Ciências e Tecnologia, Universidade do Algarve, Faro, Portugal
Anna D Grabowska
5Department of Biophysics and Human Physiology, Medical University of Warsaw, Warsaw, Poland
Luís Graça
1Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal
Clara Cordeiro
2CEAUL – Centro de Estatística e Aplicações, Faculdade de Ciências, Universidade de Lisboa, Lisbon, Portugal
4Faculdade de Ciências e Tecnologia, Universidade do Algarve, Faro, Portugal
Luís Nacul
6Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom
7Complex Chronic Diseases Program, British Columbia Women’s Hospital and Health Centre, Vancouver, British Columbia, Canada
Eliana M Lacerda
6Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom
Jesus Castro-Marrero
8Vall d’Hebron Hospital Research Institute, Division of Rheumatology, ME/CFS Unit, Universitat Autònoma de Barcelona, Barcelona, Spain
Carmen Scheibenbogen
3Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin and Berlin Institute of Health, Institute of Medical Immunology, Berlin, Germany
Francisco Westermeier
9Institute of Biomedical Science, FH Joanneum University of Applied Sciences, Graz, Austria
Nuno Sepúlveda
2CEAUL – Centro de Estatística e Aplicações, Faculdade de Ciências, Universidade de Lisboa, Lisbon, Portugal
3Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt Universität zu Berlin and Berlin Institute of Health, Institute of Medical Immunology, Berlin, Germany
10Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom
Article usage
Posted March 24, 2021.
The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput genetic, epigenetic, and gene expression studies
João Malato, Franziska Sotzny, Sandra Bauer, Helma Freitag, André Fonseca, Anna D Grabowska, Luís Graça, Clara Cordeiro, Luís Nacul, Eliana M Lacerda, Jesus Castro-Marrero, Carmen Scheibenbogen, Francisco Westermeier, Nuno Sepúlveda
medRxiv 2021.03.23.21254175; doi: https://doi.org/10.1101/2021.03.23.21254175
The SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: analysis of high-throughput genetic, epigenetic, and gene expression studies
João Malato, Franziska Sotzny, Sandra Bauer, Helma Freitag, André Fonseca, Anna D Grabowska, Luís Graça, Clara Cordeiro, Luís Nacul, Eliana M Lacerda, Jesus Castro-Marrero, Carmen Scheibenbogen, Francisco Westermeier, Nuno Sepúlveda
medRxiv 2021.03.23.21254175; doi: https://doi.org/10.1101/2021.03.23.21254175
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (695)
- Anesthesia (187)
- Cardiovascular Medicine (2817)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12506)
- Forensic Medicine (10)
- Gastroenterology (797)
- Genetic and Genomic Medicine (4372)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2821)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (889)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4140)
- Nursing (219)
- Nutrition (614)
- Oncology (2178)
- Ophthalmology (618)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (261)
- Palliative Medicine (81)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6725)
- Radiology and Imaging (1477)
- Respiratory Medicine (893)
- Rheumatology (429)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (198)
- Urology (173)